Case in point
Shaped a long-term strategy in general biocatalysis and recombinant enzymes for a global life science company, benchmarking suppliers and ranking unmet needs across biopharma, IVD, and industrial applications.
Evaluating future market opportunities, emerging technologies, or where to invest? Our strategy consulting turns complex business questions into evidence-based insights and practical recommendations.
Our differentiator
Deep healthcare expertise and rigorous primary research that delivers evidence-backed insights and confident answers.
Healthcare domain experts with decades of combined experience
In-depth understanding of markets, technologies, disease areas & regulations
Proven frameworks and analytical rigor
Strategic perspective shaped by real-world engagements
Physicians& KOLs
Hospitals &Health Systems
Patients &Caregivers
Payers
Distributors &Partners
Direct stakeholder insights
Unbiased, evidence-backed
insights you can trust
Clarity on risks, opportunities
& market dynamics
Stronger strategies
& go-to-market plans
Better decisions that
drive business impact
The impact
for you
De-risk critical
decisions
See the market
as it really is
Align stakeholders
with confidence
Move faster with
greater certainty
Create sustainable
competitive advantage
A specialist team with the reach and rigor to execute complex research and intelligence across markets, technologies, and therapy areas.
Our experience across major healthcare markets including North America, Europe, China, Japan, India, Southeast Asia, South America (LATAM), and the Middle East & Africa enables us to bring both global perspective and local market understanding to every engagement.




A snapshot of recent engagements across our service areas — each one turning a complex business question into a confident decision.
Case in point
Shaped a long-term strategy in general biocatalysis and recombinant enzymes for a global life science company, benchmarking suppliers and ranking unmet needs across biopharma, IVD, and industrial applications.
Case in point
Delivered a comprehensive market opportunity assessment for an early-stage MedTech startup, enabling informed investment and commercialization decisions for a novel endoscope designed for PCNL procedures.
Case in point
Assessed the competitive landscape for chair-side and lab-side dental products in South Korea for a global manufacturer, benchmarking competitors and mapping where its portfolio could win.
Case in point
Established a multi-market brand tracking program for a Fortune 500 healthcare manufacturer, monitoring brand awareness, perception, and competitive positioning while measuring the impact of commercial initiatives over time.
Case in point
Ran a post-market clinical follow-up survey among dentists across the US and EU5 for a global dental device manufacturer, capturing clinician-reported performance and safety evidence for MDR compliance.
Case in point
Conducted concept testing of a novel pharmaceutical therapy across key Asian markets to assess physician perceptions of clinical efficacy, differentiation, and adoption potential.
Case in point
Helped a Swedish MedTech manufacturer evaluate the commercial potential of its advanced wound management solution for the European markets and develop a practical market entry strategy.
Tell us the decision you're facing. We'll turn it into a clear, evidence-backed answer.

Evidence-led market intelligence, commercialization & clinical evidence for MedTech and BioTech.
contactus@soralifesciences.com© 2026 Sora Life Sciences. All rights reserved.